Connect Biopharma Holdings Limited (CNTB)

NASDAQ

$1.29

$+0.00

(+0.39%)

Previous Close: ⁦$1.29⁩

Market Closed

Connect Biopharma Holdings Limited (CNTB) Live Price Chart

Last updated: ⁦2026-09-21 04:10:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Connect Biopharma Holdings Limited (CNTB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.29, with a market capitalization of $80.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.06 to $3.82. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$80.61M
Open	$1.25
Day's High	$29.27
Day's Low	$0.51
Previous Close	$1.29
Volume	1.05M
Average Volume	970.05K
P/E Ratio	--
52-Week High	$3.82
52-Week Low	$1.06
Dividend Yield	--
Earnings Date	--

Connect Biopharma Holdings Limited (CNTB) Latest Closing Stock Price

Connect Biopharma Holdings Limited (CNTB) last closed at $1.29 as of 2026-09-18 23:56:00, unchanged from the previous close of $1.29.

During the latest regular trading session, CNTB traded between $0.51 and $29.27, with a volume of 1.05M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Connect Biopharma Holdings Limited (CNTB) 7-Day Stock Price Change

Over the past seven days, Connect Biopharma Holdings Limited (CNTB) moved from $2.06 to $1.29, representing a decline of 37.18% ($0.77).

The stock traded between $1.06 and $2.10 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 3.22 million shares, up versus the previous seven-day period, indicating higher trading activity.

CNTB 52-Week Price Position

Position in Range: 8.4%

52W Low$1.06

52W High$3.82

CNTB is currently trading at $1.29, placing it 8.4% of the way from its 52-week low of $1.06 to its 52-week high of $3.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Connect Biopharma Holdings Limited (CNTB)?

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Connect Biopharma Holdings Limited Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	64
Exchange	NASDAQ
Company Website	https://www.connectbiopharm.com

How to Buy Connect Biopharma Holdings Limited (CNTB) Stock on MEXC

Eligible investors can buy real shares of Connect Biopharma Holdings Limited (CNTB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CNTB and Place Your Order

Open the RealStocks trading page and search for CNTB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Connect Biopharma Holdings Limited (CNTB) stock price today?

Connect Biopharma Holdings Limited (CNTB) is currently trading at $ 1.29, up 0.31% ($0.00) from the previous close of $ 1.29. Intraday prices update in real time during regular trading hours.

2.Is CNTB stock going up or down today?

As of 2026-09-18 23:56:00, CNTB is trading at $ 1.29, up 0.31% ($0.00) from its previous close of $ 1.29. The stock has traded between $ 0.51 and $ 29.27 during today’s regular session. Past price movements do not guarantee future results.

3.What is CNTB pre-market price?

As of 2026-09-18 23:56:00, CNTB is trading at $ 1.27 in pre-market trading, down 1.94% ($0.03) from the previous close of $ 1.29. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CNTB after-hours price?

As of 2026-09-18 23:56:00, CNTB is trading at $ 1.29 in after-hours trading, unchanged from the regular-session close of $ 1.29. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CNTB stock trading now?

CNTB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CNTB sit relative to its 52-week high and low?

Over the past 52 weeks, CNTB has traded between a low of $ 1.06 and a high of $ 3.82. At $ 1.29, the stock is positioned 8.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Connect Biopharma Holdings Limited in?

Connect Biopharma Holdings Limited (CNTB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Connect Biopharma Holdings Limited's market capitalization and where is it listed?

Connect Biopharma Holdings Limited is listed on the NASDAQ exchange with a market capitalization of $ 80.61M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CNTB valued in terms of P/E ratio and EPS?

CNTB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.10. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Connect Biopharma Holdings Limited pay a dividend?

Connect Biopharma Holdings Limited pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.